Franklin Resources
ZVRA icon

Franklin Resources’s Zevra Therapeutics ZVRA Stock Holding History

Franklin Resources’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Buy
38,686
+1,892
+5% +$21K ﹤0.01% 2537
2026
Q1 		$343K Hold
36,794
– – ﹤0.01% 2613
2025
Q4 		$330K Sell
36,794
-41
-0.1% -$388 ﹤0.01% 2588
2025
Q3 		$350K Buy
+36,835
New +$369K ﹤0.01% 2595

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources's ZVRA Position: Q2 2026 in Review

Franklin Resources increased its Zevra Therapeutics (ZVRA) stake by 5.1% in Q2 2026, buying an estimated $21K and bringing the position to 38,686 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Franklin Resources first reported a position in ZVRA in Q3 2025 and has held it in 4 quarters since. 158 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Franklin Resources held 38,686 shares of Zevra Therapeutics worth $555K as of Q2 2026.
  • Franklin Resources bought 1,892 Zevra Therapeutics shares in Q2 2026, an estimated $21K.
  • Zevra Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2537 holding.
  • Franklin Resources first reported a position in Zevra Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 158 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.